Limba
|
Aloxistatin (E64d) is an irreversible and membrane-permeable cysteine proteaseinhibitor with blood platelet aggregation inhibiting activity. The cysteine protease cathepsin L is required for SARS-CoV-2 viral entry, and aloxistatin treatment reduced cellular entry of SARS-CoV-2 pseudovirions by 92.3%.
Price | 723,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Aloxistatin (E64d) is an irreversible and membrane-permeable cysteine proteaseinhibitor with blood platelet aggregation inhibiting activity. The cysteine protease cathepsin L is required for SARS-CoV-2 viral entry, and aloxistatin treatment reduced cellular entry of SARS-CoV-2 pseudovirions by 92.3%. |